Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK.
Center for Biomedical Imaging, Medical University of South Carolina, Charleston, South Carolina, USA.
Hum Brain Mapp. 2021 Jun 1;42(8):2490-2507. doi: 10.1002/hbm.25382. Epub 2021 Feb 19.
Multicompartment diffusion magnetic resonance imaging (MRI) approaches are increasingly being applied to estimate intra-axonal and extra-axonal diffusion characteristics in the human brain. Fiber ball imaging (FBI) and its extension fiber ball white matter modeling (FBWM) are such recently described multicompartment approaches. However, these particular approaches have yet to be applied in clinical cohorts. The modeling of several diffusion parameters with interpretable biological meaning may offer the development of new, noninvasive biomarkers of pharmacoresistance in epilepsy. In the present study, we used FBI and FBWM to evaluate intra-axonal and extra-axonal diffusion properties of white matter tracts in patients with longstanding focal epilepsy. FBI/FBWM diffusion parameters were calculated along the length of 50 white matter tract bundles and statistically compared between patients with refractory epilepsy, nonrefractory epilepsy and controls. We report that patients with chronic epilepsy had a widespread distribution of extra-axonal diffusivity relative to controls, particularly in circumscribed regions along white matter tracts projecting to cerebral cortex from thalamic, striatal, brainstem, and peduncular regions. Patients with refractory epilepsy had significantly greater markers of extra-axonal diffusivity compared to those with nonrefractory epilepsy. The extra-axonal diffusivity alterations in patients with epilepsy observed in the present study could be markers of neuroinflammatory processes or a reflection of reduced axonal density, both of which have been histologically demonstrated in focal epilepsy. FBI is a clinically feasible MRI approach that provides the basis for more interpretive conclusions about the microstructural environment of the brain and may represent a unique biomarker of pharmacoresistance in epilepsy.
多室弥散磁共振成像(MRI)方法越来越多地被用于估计人类大脑内轴内和轴外弥散特征。纤维球成像(FBI)及其扩展纤维球白质建模(FBWM)是最近描述的多室方法。然而,这些特定的方法尚未在临床队列中应用。具有可解释生物学意义的多个弥散参数的建模可能为开发新的、非侵入性的癫痫药物抵抗生物标志物提供了可能。在本研究中,我们使用 FBI 和 FBWM 来评估长期局灶性癫痫患者白质束的轴内和轴外弥散特性。沿着 50 个白质束的长度计算 FBI/FBWM 弥散参数,并在难治性癫痫、非难治性癫痫和对照组患者之间进行统计学比较。我们报告说,与对照组相比,慢性癫痫患者的轴外弥散率分布广泛,特别是在丘脑、纹状体、脑干和脑桥区域投射到大脑皮层的白质束的局限区域。与非难治性癫痫患者相比,难治性癫痫患者的轴外弥散标志物显著增加。本研究中观察到癫痫患者的轴外弥散改变可能是神经炎症过程的标志物,或者反映了轴突密度的降低,这两者在局灶性癫痫中均有组织学证明。FBI 是一种临床可行的 MRI 方法,为大脑微观结构环境提供了更具解释性的结论基础,并且可能是癫痫药物抵抗的独特生物标志物。